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Total biosynthesis of opiates by stepwise
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Opiates such as morphine and codeine are mainly obtained by extraction from opium
poppies. Fermentative opiate production in microbes has also been investigated, and
complete biosynthesis of opiates from a simple carbon source has recently been accom-
plished in yeast. Here we demonstrate that Escherichia coli serves as an efficient, robust and
flexible platform for total opiate synthesis. Thebaine, the most important raw material in
opioid preparations, is produced by stepwise culture of four engineered strains at yields of
2.1mg l 1 from glycerol, corresponding to a 300-fold increase from recently developed yeast
systems. This improvement is presumably due to strong activity of enzymes related to
thebaine synthesis from (R)-reticuline in E. coli. Furthermore, by adding two genes to the
thebaine production system, we demonstrate the biosynthesis of hydrocodone, a clinically
important opioid. Improvements in opiate production in this E. coli system represent a major
step towards the development of alternative opiate production systems.
DOI: 10.1038/ncomms10390 OPEN
1 Applied Microbiology laboratory, Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, 1-308 Suematsu, Ishikawa 921-
8836, Japan. 2 Department of Applied Molecular Biology, Graduate School of Biostudies, Kyoto University, Oiwake-cho, Kitashirakawa, Kyoto 606-8502,
Japan. 3 Breeding and Physiology Laboratory, Tsukuba Research Center for Medicinal Plant Resources, National Institutes of Biomedical Innovation, Health and
Nutrition, 1-2 Hachimandai, Tsukuba 305-0843, Japan. 4Department of Plant Gene and Totipotency, Division of Integrated Life Science, Graduate School of
Biostudies, Kyoto University, Oiwake-cho, Kitashirakawa, Kyoto 606-8502, Japan. Correspondence and requests for materials should be addressed to H.M.
(email: minami@ishikawa-pu.ac.jp).
NATURE COMMUNICATIONS | 7:10390 | DOI: 10.1038/ncomms10390 |www.nature.com/naturecommunications 1
O
piates are commonly used painkillers that are prescribed
for illnesses ranging from cancer to rheumatism and
toothaches. They are typically extracted from plants, and
more efficient production of opiate has been attempted.
Biotechnology methods for poppy cultivation to increase yields
have been studied extensively1–3; however, complex and
unknown mechanisms that regulate biosynthetic pathways
might make it difficult to increase opiate yields. Although there
are several examples of successful chemical opiate synthesis4,
cost-effective methods have not been established because of the
complex molecular structure of opiates. Alternatively, as a next-
generation strategy, complete biosynthesis of opiates via microbes
has also attracted attention because it does not require specific
substrates other than inexpensive carbon sources (for example,
glucose or glycerol)5–8, and has potential for improvements in
quality and quantity.
The complete biosynthesis of the opiate thebaine and opioid
hydrocodone in yeast are the first examples of successful
production from simple substrates8. The yeast fermentation
system is sophisticated; however, thebaine and hydrocodone
yields are still limited in that system.
Material production using engineered E. coli has been studied
extensively since the 1960s9, and information related to metabolic
engineering has accumulated. The major production targets are
primary metabolites, including amino acids, which have yields of
B1mol l 1. Because opiates are synthesized from two L-tyrosine
molecules, high amino-acid productivity by E. coli would be
helpful to construct a practical production system for opiates.
E. coli exhibits higher productivity of opiate intermediates, such
as L-tyrosine10, L-dopa5,11, tetrahydropapaveroline (THP)12 and
reticuline12, than yeast systems6,7,13,14. Therefore, to construct a
practical opiate production system, we chose E. coli as a
production host.
Here we demonstrate the total synthesis of opiates using four
E. coli strains.
Results
(R)-reticuline production by methyltransferases. Previously, we
achieved the total biosynthesis of (S)-reticuline, a precursor of
thebaine, from glycerol in a shake-flask culture (yield, 103mM)
using an engineered E. coli strain15. Previous studies have shown
that the synthesis of the R-form of reticuline should be the
initial production step (Fig. 1 and Supplementary Fig. 1)5.
To produce (R)-reticuline, we examined the combination of
three methyltransferases derived from Coptis japonica:
6-O-methyltransferase (6OMT)16, coclaurine N-methyltransferase
(CNMT)17 and 40-O-methyltransferase (40OMT)18; these would
theoretically synthesize racemic forms of reticuline from
(R,S)-THP (Fig. 2a). However, only the S-form is produced by
the strain that expresses the three methyltransferases (AN1752)
cultured in (R,S)-THP-supplemented medium (Fig. 2b,c).
After extensive empirical trials, we found that the CNMT- and
40OMT-expressing strain (AN1600) could produce R-form
reticuline (Fig. 2d). Because it has been reported that 40OMT has
6OMT activity towards norcoclaurine3, we speculated that 40OMT
has 6OMT activity towards THP as well as norcoclaurine. To verify
this, an enzyme assay was conducted with crude extract from
6OMT- or 40OMT-expressing strains (AN1472 or AN1028,
respectively). When 40OMT was incubated with THP, both
6-O-methyl THP and 40-O-methyl THP were synthesized,
whereas only 6-O-methyl THP was detected in the reaction
containing the 6OMT crude extract (Supplementary Fig. 2a,b).
Indeed, 6,40-O-dimethyl THP was synthesized by 40OMT only
(Supplementary Fig. 2c). These results suggested that 40OMT has
6OMT activity towards THP, and consequently, reticuline could be
produced without 6OMT (Fig. 2d). However, it was not clear why
the R-form of reticuline was produced by the CNMT and 40OMT
expression strains, and further investigations are required to
resolve this issue (described in the Supplementary Note 1).
When (R,S)-reticuline was produced from various concentra-
tions of (R,S)-THP by the two methyltransferases expression
strain (AN1600), (S)-reticuline production increased as
(R,S)-THP increased, whereas (R)-reticuline formation decreased
slightly, presumably owing to an S-form preference by CNMT
and/or 40OMT (Fig. 2e). The maximum amount of (R)-reticuline
was obtained using fermentatively produced (R,S)-THP at
99.2 mM in the AN1600 culture. The (R,S)-reticuline yield
reached 48±11 mM (16±3.6mg l 1), including 15±4.2 mM
(4.9±1.4mg l 1) of the R-form. Thus, (R,S)-THP was used at
B100 mM to produce downstream compounds in subsequent
experiments.
Selection of a suitable cytochrome P450 reductase (CPR).
During the establishment of the conditions necessary to produce
(R,S)-reticuline using E. coli with 40OMT and CNMT expression,
the enzyme that converts (S)-reticuline to (R)-reticuline,
known as STORR, was identified (Supplementary Fig. 1)8,19,20.
Therefore, we also examined the efficiency of STORR in E. coli.
As STORR contains a P450 enzymatic domain (CYP80Y2), and
requires the reductase partner of P450 enzymes, CPR, we
searched for a suitable CPR for P450s in E. coli. We had CPRs
of Arabidopsis thaliana (ATR2), Papaver somniferum (PsCPR)
and Rattus norvegicus (RnCPR) as laboratory stocks. Because the
N-terminal deletion mutant of ATR2 is functional in E. coli21, a
45-amino-acid deletion of ATR2 (ATR2Ncut) was also prepared.
The CPR activity towards bovine cytochrome c was verified using
the crude extract from CPR-expressing strains22. The crude
extract contained endogenous E. coli enzymes that catalyse
nicotinamide adenine dinucleotide phosphate (NADPH);
therefore, NADPHase activity was observed, even in the control
sample (Supplementary Table 1). Although the activity of PsCPR
was almost identical to that of the control, others had significant
activity. Because ATR2 activity was strongest, it was used as a
reductase partner of P450 enzymes in opiate production by E. coli.
Functional expression of STORR in E. coli. Generally, P450
expression is difficult in E. coli. Because some P450 enzymes are
successfully expressed in E. coli only after the deletion of their
N-terminus23–26, N-terminal-deleted STORR (STORRNcut) was
constructed in addition to full-length STORR. These STORRs
were expressed with ATR2 and cultured in medium containing
(S)-reticuline, which was biosynthesized from glycerol as
described previously15. SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) analysis showed that the deletion of N-terminus
was effective for protein expression (Supplementary Fig. 3a).
However, neither STORR expression strain produced detectable
R-form reticuline (Supplementary Fig. 3b–d). Because P450 is a
haemoprotein, the addition of 5-aminolevulinic acid (5-ALA),
a precursor of haeme, is sometimes required for functional
expression in E. coli27. Therefore, 5-ALA was added to the culture
medium at the same time as isopropyl-b-D-thiogalactopyranoside
(IPTG) induction. As a result, small amount of (R)-reticuline was
detected in the culture medium of the STORRNcut expression
strain, indicating that STORR was functional in E. coli, although
the N-terminal deletion and 5-ALA addition were required
(Supplementary Fig. 3e,f). However, (R)-reticuline production by
STORR was low (Supplementary Fig. 3f, less than 10 mM) and
required the addition of an expensive compound, 5-ALA;
therefore, it is not applicable for the practical production of
opiates in current conditions. Thus, to construct an opiate
production system in E. coli, we attempted to develop
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(R,S)-reticuline production using two methyltransferases from
(R,S)-THP.
Functional expression of SalS in E. coli. The next step required
for the production of opiates is the conversion of (R)-reticuline to
salutaridine, which is catalysed by the P450 enzyme salutaridine
synthase (SalS; Fig. 1, Supplementary Fig. 1)28. Human P450s,
CYP2D6 and CYP3A4 also have SalS activity, and have been
successfully expressed in E. coli27,29,30. However, because these
P450s produce undesirable by-products29, they are unsuitable for
the practical production of opiates. Thus, we attempted functional
expression of SalS in E. coli. We constructed two SalS variants,
full-length SalS (SalS) and N-terminus deleted (SalSNcut), as in
the case of STORR. These SalS proteins were expressed with
ATR2. SDS–PAGE analysis showed that SalSNcut was expressed
in E. coli, whereas the wild-type SalS was not, suggesting that
the N-terminus sequence negatively affected SalS expression in
E. coli, similar to STORR (Supplementary Figs 2a and 4a). These
strains were grown on medium containing pure (R,S)-reticuline,
and we measured the production of salutaridine. According to
liquid chromatography mass spectrometry (LC-MS) analysis, the
specific peak was observed in the medium of the SalSNcut-
expressing strain, and the tandem mass spectrometry (MS/MS)
fragment pattern of the peak was almost identical to that of pure
salutaridine (Supplementary Fig. 4b,c), indicating that SalSNcut
had salutaridine synthetase activity in E. coli. In the medium of
the full-length SalS-expressing strains, a significant peak was
observed at the same retention time as the salutaridine standard
(an asterisk in Supplementary Fig. 4b); however, we could not
confirm their identity because the MS/MS fragment patterns of
the peak was ambiguous. In contrast to STORR, the addition of
5-ALA was not required for salutaridine synthetic activity of SalS
(Supplementary Fig. 5), indicating that this property of SalSNcut
is adequate for the practical production of opiates. Thus, we
decided to use SalSNcut for the total biosynthesis of opiates.
Thebaine production from authentic (R,S)-reticuline. To
validate the activities of salutaridine reductase (SalR)31 and
salutaridinol 7-O-acetyltransferase (SalAT)32, the last two enzymes
in the thebaine synthetic pathway (Fig. 1 and Supplementary
Fig. 1), their corresponding genes were expressed in the
salutaridine-producing E. coli strain AN1096 to generate the
thebaine-producing strain AN1829. Measurement of thebaine
production from authentic (R,S)-reticuline showed a thebaine-
specific peak at m/z¼ 312 (Fig. 3a). The MS/MS fragment pattern
of the peak was almost identical to that of pure thebaine (Fig. 3b),
indicating that both SalR and SalAT were functional in E. coli.
The thebaine yield was 57±4.6mM using pure (R,S)-reticuline at
200mM, containing the R-form at B100mM.
We determined that glucose was essential for thebaine
production from (R,S)-reticuline (Supplementary Fig. 5). In
thebaine production, acetyl-CoA is required to convert salutar-
idinol to salutaridinol 7-O-acetate (Supplementary Fig. 1), and






































































Figure 1 | Total biosynthesis of thebaine using four-step culture. The brackets indicate the reactions in the individual strain of each culture step. ATR2,
NADPH-cytochrome P450 reductase 2; CNMT, coclaurine N-methyltransferase; DODC, dopa decarboxylase; MAO, monoamine oxidase; SalSNcut,
N-terminally-truncated salutaridine synthase; SalR, salutaridine reductase; SalAT, salutaridinol acetyltransferase; TYR, tyrosinase; 3,4-DHPAA, 3,4-
dihydroxyphenylacetaldehyde; 40OMT, 30-hydroxy-N-methylcoclaurine 40-O-methyltransferase.
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and SalR require NADPH as a cofactor, which is mainly
synthesized in the pentose phosphate pathway during glucose
metabolism. These observations explain why glucose is essential
for thebaine production.
Stepwise culture strategy for opiates production. For optimal
(R)-reticuline production, the amount of (R,S)-THP should be
limited (Fig. 2e). Therefore, the thebaine production pathway
should be divided into two: the total biosynthesis of (R,S)-THP,
and thebaine production from (R,S)-THP. Although tyrosinase is
essential for dopamine production in our system (Fig. 1),
tyrosinase degrades THP12. To avoid the undesirable action of
tyrosinase, a stepwise culture method was employed using the
dopamine production strain AN1126 and (R,S)-THP production
strain AN1055. Using this method, a total biosynthesis system
for (R,S)-THP was successfully constructed12. Thus, for total
biosynthesis of thebaine, the thebaine production pathway
should be divided into three: dopamine production, conversion
of dopamine to (R,S)-THP and thebaine production from
(R,S)-THP. These pathways were individually constructed in
three strains, resulting in the dopamine producer AN1126, a
strain that produces (R,S)-THP from dopamine (AN1055) and
AN1998, which produces thebaine from (R,S)-THP. Although
we attempted thebaine production using three-step cultures,
thebaine was not produced by the system, regardless of the
presence/absence of IPTG. Although IPTG negatively affects
(R,S)-reticuline production (Supplementary Fig. 6), the titre of
thebaine was increased by adding IPTG (Supplementary Fig. 5);
therefore, we speculated that opposing effects of IPTG on
(R,S)-reticuline and thebaine productions resulted in the low
productivity of AN1998 strain. Hence, (R,S)-reticuline production
step would better be separated from the thebaine production step.
Thus, we decided to construct the total biosynthesis system
using a four-step culture method using four strains: AN1126,
AN1055, the (R,S)-reticuline producer AN1600 and AN1829,
which produces thebaine from (R,S)-reticuline (Fig. 1 and
Supplementary Fig. 7).
Thebaine biosynthesis using a four-step culture system. For
the first and second steps, total biosynthesis of (R,S)-THP was
performed as described previously12, and the (R,S)-THP yield was
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Figure 2 | Total biosynthesis of (R,S)-reticuline. (a) (R,S)-Reticuline synthetic pathway from (R,S)-THP. (b) The chirality analysis of pure (R,S)-reticuline.
(c) The products from the culture of AN1752. (d) The products from the culture of AN1600. Experiments in b,c were conducted three times,
and same tendency was observed. (e) (R,S)-Reticuline production following the addition of various concentrations of (R,S)-THP to the AN1600 culture.
The error bar indicates the standard deviation of three independent experiments.
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(R,S)-THP (109 mM) was added to the (R,S)-reticuline production
culture, yielding 16.9 mM (R)-reticuline. In the fourth step, the
same volume of (R,S)-reticuline-containing supernatant (final
concentration, 8.5 mM) was added to the culture of the thebaine
producer. A thebaine yield of 6.8±0.67 mM (2.1±0.21mg l 1)
was obtained 15 h post initiation of the fourth step (Fig. 3c). The
yields achieved were a 300-fold improvement compared with
those of the latest yeast system8.
Hydrocodone biosynthesis using a four-step culture system.
Hydrocodone is one of the most frequently used opioids and
can be produced from thebaine using two enzymes, thebaine
6-O-demethylase and morphinone reductase (MorB;33 Fig. 4a).
To evaluate the ability of the thebaine total biosynthesis system
to produce medical opioids, we constructed a hydrocodone
producer by introducing the genes encoding the two enzymes
into the thebaine producer, resulting in strain AN1942 (Fig. 4a).
The four-step culture system was used for hydrocodone
production. A specific peak in the AN1942 culture was
observed, and the MS/MS fragment pattern was identical to
that of the hydrocodone standard (Fig. 4b,c). The hydrocodone-
producing culture yielded 1.2±0.50 mM (0.36±0.15mg l 1)
codeine equivalents of hydrocodone, indicating that the
thebaine total biosynthesis system was applicable for the
biosynthesis of opioids.
Discussion
The E. coli opiate production system developed in this study does
not require specific substrates and resulted in 2.1mg l 1 thebaine
production, which is a 300-fold improvement compared with the
reported yeast system8. This large improvement is associated with
high enzyme activity in E. coli. In the yeast system, thebaine titres
are B0.2 mM from 1mM (R,S)-THP; the conversion efficiency is
typically only 0.02% (ref. 8). However, in the E. coli system, the
conversion efficiency of thebaine from (R,S)-THP was 12.5%
(6.8 mM thebaine was produced from 54.5 mM (R,S)-THP diluted
via stepwise culture). As the (R,S)-reticuline production system in
yeast exhibits a 10% conversion efficiency of (R,S)-reticuline from
(R,S)-THP34, the large difference in thebaine productivity
between E. coli and yeast can be attributed to the activity of
SalS, SalR and SalAT, which are required for thebaine synthesis
from (R)-reticuline. In another yeast system, the thebaine
conversion efficiency from (R)-reticuline is only B1% (ref. 7).
The conversion efficiency of thebaine from biosynthesized
(R)-reticuline reached 80% in the E. coli system, indicating that
the activity of SalS, SalR and SalAT was much stronger in E. coli
than in yeast. This strong activity may be related to high
expression of these enzymes or high productivity of co-factor(s),
for example, haeme, NADPH and/or acetyl-CoA in E. coli. These
results demonstrated that E. coli is suitable for opiate production,
despite concerns related to the difficulty in expressing plant genes
in the species13,34.
Despite the high conversion efficiency of thebaine from
(R)-reticuline, the production yield of thebaine was relatively
low in this total biosynthesis system. These results suggested that
the productivity of (R)-reticuline is a major rate-limiting step.
To develop a practical production system for opioids, increasing





































Figure 3 | Thebaine production from pure (R,S)-reticuline or (R,S)-reticuline synthesized by total biosynthesis. (a) LC-MS analysis of thebaine
(m/z¼ 312) from the culture of the parental strain (salutaridine producer, AN1096; upper panel), the thebaine producer (AN1829; mid panel) and the
thebaine standard (lower panel). (b) MS/MS fragment pattern of the products of AN1829 (upper panel) and the thebaine standard (lower panel).
Experiments in a and b were conducted at least three times, and same tendency was observed. (c) Time-course analysis of the total biosynthesis of
thebaine from fermentatively produced (R,S)-reticuline in the four-step culture. (R,S)-Reticuline synthesized by total biosynthesis was added to the fourth
step of the culture at time zero. The error bar indicates the standard deviation of three independent experiments.
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We demonstrated two ways to produce (R)-reticuline, that is,
using STORR or the irregular activity of a methyltransferase.
Although the conversion of racemic THP via methyltransferases
was used to reconstruct opiate biosynthesis in this study, half of
the reticuline that was produced, (S)-reticuline, was not used for
opiate production. On the other hand, STORR has low activity in
E. coli, even after the addition of an expensive cofactor for
(R)-reticuline production. To improve (R)-reticuline productivity,
these drawbacks should be overcome by metabolic engineering
strategies such as protein engineering for practical production.
Engineered yeast can convert thebaine into various opiates
such as morphine33. Theoretically, other opioids in addition to
hydrocodone can be produced by integrating opioid biosynthetic
enzymes such as codeinone reductase (COR), codeine
demethylase and morphine dehydrogenase into our thebaine
total biosynthesis system. Alternatively, a hybrid E. coli-yeast
system could enable opioid production35. Thus, it is possible, in
principle, to produce various opioids from a simple carbon source
using microbes.
Stepwise culture has some advantages over single-step culture
in the thebaine production system. Because tyrosinase degrades
THP, dividing the THP production pathway into two parts
enables efficient THP production12. Thus, stepwise culture
bypasses undesirable reactions in which upstream enzymes act
on downstream compounds. The other benefit of stepwise culture
is that it permits the individual optimization of each culture step,
like chemical synthesis methods. In this study, IPTG had a
positive effect on thebaine production, although it diminished
(R)-reticuline production (Supplementary Figs 5 and 6).
Accordingly, dividing the thebaine synthetic pathway from
(R,S)-THP into two parts via stepwise culture enabled
successful opiate production. However, it was not clear why
IPTG had the opposite effect. To construct a practical production
system, we aim to verify the necessity of separating this step by
elucidating the exact mechanism that does not allow the
production of thebaine with (R,S)-reticuline production in our
future research.
Recently, microbial production of plant secondary metabolites
has attracted attention5,6,8,13,36,37. These compounds require
multistep reactions from a simple carbon source, and are
associated with undesirable reactions and enzyme inhibition.
The efficient production of these compounds may be achieved
using stepwise culture, which would minimize problems that arise
in multi-step reactions. Furthermore, a stepwise culture method
enables the segmentation of a synthetic pathway, and that
facilitates the production of similar compounds. In fact, the
central intermediate in benzylisoquinoline alkaloid biosynthesis,
(S)-reticuline, is used for the production of protoberberine with
the berberine bridge enzyme, scoulerine O-methyltransferase and
CYP719A1 (ref. 38). Similarly, aporphine alkaloids are produced
from (S)-reticuline with CYP80G2 and CNMT enzymes35,
whereas benzophenanthridine alkaloids are produced via
scoulerine with CYP719A5, CYP719A3, TNMT, MSH and
P6H39. By constructing these enzyme expression strains, and
using an (S)-reticuline production step, a stepwise culture method
can enable the production of various kinds of alkaloids. Thus,
stepwise culture methods enable flexibility in the production of































































Figure 4 | Total biosynthesis of hydrocodone. (a) Schematic representation of the total biosynthesis of hydrocodone. (b) LC-MS analysis of hydrocodone
(m/z¼ 300) from the culture of the parental strain (thebaine producer, AN1829; upper panel), hydrocodone producer (AN1942; mid panel) and the
peak standard of hydrocodone (lower panel). The peak indicated by the arrow was analysed for its MS/MS fragment pattern. (c) MS/MS fragment
pattern of the products of AN1942 (upper panel) and the peak standard of hydrocodone (lower panel). Experiments in b,c were conducted three times,
and same tendency was observed.
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methods. The E. coli system developed in this study thus
represents a potentially useful platform for the further
development aimed at the industrial production of opiates.
Methods
Plasmids and bacterial strains used in this study. Plasmids and bacterial strains
are listed in Supplementary Tables 2 and 3, respectively.
Construction of pCDF23, pCOLA23 and pAC23. pCDF23, pCOLA23 and
pAC23 were generated from pCDFDuet-1, pCOLADuet-1 and pACYCDuet-1,
respectively. Each plasmid sequence, other than the T7 promoter to the terminator
region containing a multi-cloning site (Pro-MCS-Ter), was amplified by PCR with
appropriate primers (Supplementary Table 4). Amplicons were ligated to the
Pro-MCS-Ter of pET23a, also obtained by PCR, using an In-Fusion HD cloning kit
(Clontech). Thus, the Pro-MCS-Ter regions of pCDFDuet-1, pCOLADuet-1 and
pACYCDuet-1 were replaced with Pro-MCS-Ter of pET23a, generating pCDF23,
pCOLA23 and pAC23, respectively.
Gene cloning. All genes were amplified by PCR using the primer sets listed in
Supplementary Table 4, and were initially cloned between the NdeI and BamHI
sites of pET23a, pCDF23 or pAC23 using the In-Fusion HD cloning kit or a
conventional ligation method to fuse them with an IPTG-inducible T7 promoter.
When required, genes with the T7 promoter were reamplified by PCR using primer
set pr339 and pr379, and cloned into the XhoI site of the appropriate plasmid.
These primers were designed such that only one XhoI site at downstream of the
cloned gene was regenerated after cloning, meaning that each gene could be cloned
in tandem into the vector using the XhoI site from one to the next. The plasmids
used for total biosynthesis of opiates are represented in Supplementary Fig 5.
Codon usage of all genes, except for tyrAfbr, aroGfbr, tktA, ppsA and DODC,
was optimized for E. coli expression, and these sequences are listed in
Supplementary Fig. 8.
Gene cloning from Papaver somniferum L. cv. Ikkanshu. SalS, SalR and SalAT
were amplified from a P. somniferum L. cv. Ikkanshu cDNA pool using primer
sets PsSalSNncS/PsSalSCncA, PsSalRedNncS/PsSalRedCncA and PsSalATNncS/
PsSalATCncA, respectively. These fragments were cloned into an EcoRV site of
vector pT7-Blue (Novagen), and their sequences were analysed (Supplementary
Fig. 9).
Selection of a suitable CPR for expression in E. coli. ATR2, ATR2Ncut, PsCPR
and RnCPR were expressed in BL21 (AN1067, AN1068, AN1069 and AN1070,
respectively). Overnight cultures of these strains were inoculated into 50ml of TB
medium (per litre: 12 g tryptone (Difco), 24 g yeast extract (Diffco), 9.4 g K2HPO4,
2.2 g KH2PO4 and 4ml glycerol) supplemented with 50mg l 1 ampicillin in a
baffled shake flask at 25 C. IPTG (1mM) was added for induction at 12 h
post inoculation. Following further incubation for 12 h, cells were harvested by
centrifugation and suspended in 100mM sodium phosphate buffer (pH 7.3)
containing 10% glycerol. The crude extract containing a CPR was obtained by
centrifugation following sonication. The protein concentration was measured using
a BCA Protein Assay Kit (Pierce). Verification of CPR activity was carried out by a
method of P450 reductase activity assay22. The reaction mixture contained 2.1 mg
of total protein, 100mg of bovine cytochrome c (Sigma), 100 mM NADPH and
100mM potassium phosphate (pH 7.3). The samples were incubated at 25 C for
5 or 10min. Degradation ratio of NADPH was measured at 550 nm by comparing
before with after incubation.
STORR activity in E. coli. Strains expressing full-length STORR or STORRNcut
(AN1989 and AN1991, respectively) were cultured in 50ml of TB medium
supplemented with 50mg l 1 ampicillin for 12 h, and then induced by adding
1mM IPTG with or without 1mM 5-ALA. Following further incubation for 12 h,
biosynthesized (S)-reticuline15 was added to the cultures (final concentration,
44mM). The samples were harvested 12 h after the addition of (S)-reticuline, and
the chirality of reticuline was analysed by LC-MS. For verification of protein
expression, the cultures were harvested before (R,S)-reticuline addition and
resuspended in 100mM sodium phosphate buffer (pH 7.3). The cells were lysed by
sonication, and each sample was separated into soluble and insoluble fractions by
centrifugation for SDS–PAGE analysis.
Validating the 6OMT activity of 40OMT. The crude extract containing the
methyltransferase was obtained as described above. (R,S)-THP, the substrate of the
reactions, was synthesized from dopamine following cultivation of strain AN1055,
as described previously12. The supernatant containing 3.8mM (R,S)-THP was
applied to an Oasis HLB solid-phase extraction cartridge (Waters), and the eluate
was freeze-dried. The standard reaction mixture contained 100 mM (R,S)-THP,
100mM potassium phosphate (pH 7.3), 1mM S-adenosylmethionine toluene
sulfonate and 22mg of total protein in 100ml. The samples were incubated at 37 C,
and the reaction was stopped by adding 2% trichloroacetate. 6-O-Methyl THP,
40-O-methyl THP and 6,40-O-dimethyl THP were confirmed by their retention
times and MS/MS fragment patterns (daughter ions: 6-O-methyl THP, m/z¼ 178
and 123; 40-O-methyl THP, m/z¼ 164 and 137; 6,40-O-dimethyl THP, m/z¼ 178
and 137).
SalS activity in E. coli. Strains AN1096 and AN1420 were cultured in 50ml of
TB medium for 12 h, and then induced by adding 1mM IPTG. Following
further incubation for 12 h, pure (R,S)-reticuline was added to the cultures (final
concentration, 100 mM). The samples were harvested 12 h after (R,S)-reticuline
addition, and the salutaridine content was analysed by LC-MS. SDS–PAGE analysis
was conducted as mentioned above.
Total biosynthesis of (R,S)-THP using two strains. Total biosynthesis of
(R,S)-THP was performed as previously described12. To produce dopamine in the
first step, AN1126 was cultured in 1 l of TB medium in a jar-fermenter with
glycerol feeding. Dopamine (11.2mM) was produced from 89 g of glycerol.
Dopamine-containing supernatant was harvested by centrifugation and stored at
 80 C until further use. To produce (R,S)-THP in the second step, AN1055 was
cultured in 50ml of TB medium for 12 h and monoamine oxidase expression was
induced by adding IPTG to 1mM. After further cultivation for 12 h, cells were
harvested by centrifugation and resuspended in the same volume of dopamine-
containing supernatant. The sample was mixed with 100mM 2-(N-morpholino)
ethanesulfonic acid and 10mM ascorbate and incubated for 12 h at 29 C. The
(R,S)-THP-containing supernatant was harvested by centrifugation and stored at
 80 C until further use. In this paper, we used two preparations of (R,S)-THP
from total biosynthesis, containing 893 mM (Fig. 2) and 983 mM (in total
biosynthesis of opiates) (R,S)-THP.
(R,S)-reticuline production. Strain AN1600 was cultured in 50ml of TB medium
for 24 h. IPTG induction was not performed because IPTG inhibits (R,S)-reticuline
production (Supplementary Fig. 1). The indicated concentration of harvested
(R,S)-THP in Fig. 2e was added to the culture along with 1% glucose, and the
culture was incubated for 12 h at 25 C. For thebaine production, a one-eighth
volume of harvested (R,S)-THP was used. (R,S)-Reticuline-containing supernatant
was harvested by centrifugation and stored at  80 C.
Opiate production. Strains AN1829 and AN1942 were cultured in 50ml of TB
medium for 12 h at 25 C and then induced by adding IPTG to 1mM. At 12 h post
induction, the cultures were mixed with 200mM pure (R,S)-reticuline or the same
volume of (R,S)-reticuline synthesized by total biosynthesis, along with 1% glucose.
These samples were further incubated at 25 C.
Preparation of hydrocodone as a peak standard. Hydrocodone is not
commercially available in Japan; therefore, a hydrocodone standard for
identification by LC-MS analysis was synthesized from codeine by an enzymatic
method using COR and MorB33. Crude extracts from COR- and MorB-expressing
strains (AN1304 and AN1685, respectively) were obtained by sonication as
described above. The hydrocodone synthesis reaction mixture contained 100mM
potassium phosphate buffer (pH 7.3), 1.7mM codeine, 5mM NADH and
260 mgml 1 of total protein from the crude extracts. The reaction was conducted
at 37 C for 3 h and stopped by the addition of 2% trichloroacetate. Samples were
purified by Oasis HLB solid-phase extraction cartridge (Waters).
Detection and quantification of chemical compounds. To measure chemical
compounds, the culture medium was collected and proteins were precipitated with
2% trichloroacetate. All compounds, except for hydrocodone, were separated by an
Agilent HPLC system (Agilent) as follows: column, TSKgel ODS-80Ts
(4.6 250mm2, 5-mm particles; Tosoh); solvent system, A: 0.1% acetic acid in
water, B: 0.1% acetic acid in acetonitrile; gradient modes: 90% A (0–5min),
90–60% A (5–20min) and 10% A (20–30min); flow rate, 0.5mlmin 1 at 40 C.
In the case of hydrocodone, samples were separated by TSKgel ODS-100 S
(4.6 250mm2, 5-mm particles; Tosoh) using solvent A: 0.1% dimethylamine in
water and solvent B: 0.1% dimethylamine in acetonitrile, using the same gradient
methods described for the other compounds. The chirality of (R,S)-reticuline
was analysed using CHIRALCEL OD-H (4.6 250mm2, 5-mm particles; Daicel
Chemical Industries) with hexane:2-propanol:diethylamine (72:28:0.1) as a solvent
flowing at 0.55mlmin 1 at 40 C. The separated supernatant was analysed by
LC-MS and LC-MS/MS (3200 QTRAP, Applied Biosystems) using the selected ion
mode: THP (m/z¼ 288), reticuline (m/z¼ 330), salutaridine (m/z¼ 328), thebaine
(m/z¼ 312), codeine (m/z¼ 300), hydrocodone (m/z¼ 300) and oxycodone
(m/z¼ 316). Compounds were identified by comparison with pure compounds
with regard to their retention time and the fragmentation spectrum in LC-MS/MS.
The amounts of THP, reticuline and thebaine were estimated from standard curves
using Analyst 1.4.1 software (Applied Biosystems). Hydrocodone concentrations
were estimated as equivalents of codeine.
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